A phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas.
D000328:Adult; D000368:Aged; D001254:Astrocytoma / Q000188:drug therapy / Q000532:radiotherapy; D001932:Brain Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D002330:Carmustine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003037:Cobalt Radioisotopes; D004359:Drug Therapy, Combination; D005909:Glioblastoma / Q000188:drug therapy / Q000532:radiotherapy; D005910:Glioma / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D008875:Middle Aged; D011882:Radiotherapy, High-Energy
D003037:Cobalt Radioisotopes; D002330:Carmustine; D006918:Hydroxyurea